Celon Pharma S.A. (8RP)
FSX
Real-time Data
06:00 AM
Day's Range
4.5152 wk Range
4.26Overview - 8RP - Celon Pharma S.A.
Key Statistics
Valuation
P/E (Trailing)
‪10.63‬
PEG Ratio
‪-0.01‬
Price / Book
‪0.69‬
Profitability
Gross Margin
‪70.66%‬
Profit Margin
‪42.57%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-1.27%‬
Return on Equity
‪22.84%‬
Ownership
Shares Outstanding
53.85M
Float
23.82M
Held by Insiders
‪55.69%‬
Held by Institutions
‪18.36%‬
Price stats
Beta
‪0.62‬
50-Day Avg
‪4.58‬
200-Day Avg
‪4.75‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - 8RP - Celon Pharma S.A.
Peers - 8RP - Celon Pharma S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 8RPFSXCelon Pharma S.A.190.27MMarket Cap-5.52%52-week change10.40P/E (Trailing)‪42.57%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation107.87BMarket Cap+24.53%52-week change35.09P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA59.69BMarket Cap+19.31%52-week change23.51P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR59.12BMarket Cap+20.59%52-week change23.25P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG42.44BMarket Cap+22.10%52-week change58.15P/E (Trailing)‪14.57%‬Profit Margin
- H6D0FSXHaleon plc37.06BMarket Cap+1.29%52-week change20.06P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - 8RP - Celon Pharma S.A.
About
Celon Pharma S.A. is a research-oriented biopharmaceutical company based in Poland, known for its focus on developing innovative therapies to address unmet medical needs. The company's primary purpose is to discover and commercialize novel treatments across various therapeutic areas, including oncology, neurology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
